India, Oct. 29 -- In pharmaceuticals, the evolution of enterprise technology is closely tied to the demands of scientific research, manufacturing quality and patient safety. For Rakesh Bhardwaj, Global CIO, Lupin, AI's value lies in the decision advantage it can bring across this chain, supported by reliable data and compliance built into processes.

In conversation with DATAQUEST, Bhardwaj explains how Lupin narrowed more than 150 ideas to five priorities with its executive team, why it is building an enterprise-wide data foundation, and how the CIO's role is expanding from service delivery to business orchestration.

Moving into pharma brought a different industry context, with a strong emphasis on domain expertise and regulatory requir...